GAD1 and type 1 diabetes mellitus: Immunotherapy with major islet β-cell antigens such as insulin, glutamic acid decarboxylase (GAD), or heat shock protein (hsp60), with or without immunomodulators, was shown to interfere with or prevent T1D onset [13–17].